FDA Approves Merck's NOXAFILA (posaconazole) Delayed-Release Tablets

Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFILA 100 mg delayed-release tablets.

http://www.pressreleasepoint.com/fda-approves-merck-s-noxafil-posaconazole-delayed-release-tablets